Earnings
OTLK
1.330
+1.53%
0.020
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-09-30
12.54M
--
--
--
--
--
0.00
--
--
--
5.41M
0.00
17.94M
494.24K
--
900.00K
--
--
--
--
394.45K
1.79M
19.73M
--
2.39M
0.00
--
--
--
--
--
7.94M
--
--
--
1.86M
15.89M
946.68K
--
--
--
70.77K
1.02M
16.91M
1.27M
291.27M
-289.72M
--
--
--
2.83M
2.83M
19.73M
FY 2019-09-30
8.02M
--
--
--
--
--
0.00
--
--
--
4.99M
500.00K
13.50M
3.18M
--
--
--
--
--
--
457.48K
3.63M
17.14M
--
2.28M
6.70M
--
--
--
--
--
4.62M
--
--
--
1.86M
20.29M
3.42M
--
--
--
4.20M
7.61M
27.90M
286.10K
238.06M
-254.48M
--
--
--
-10.77M
-10.77M
17.14M
FY 2018-09-30
1.72M
--
--
--
--
--
0.00
--
--
--
1.59M
--
3.30M
18.49M
--
--
--
--
--
--
491.04K
18.98M
22.28M
--
3.61M
13.18M
--
--
--
--
--
6.46M
--
--
--
3.59M
32.04M
3.55M
--
--
--
7.50M
11.05M
43.09M
722.20K
190.04M
-216.31M
--
--
--
-20.81M
-20.81M
22.28M
FY 2017-09-30
3.19M
--
--
--
--
--
0.00
--
--
--
719.09K
--
3.90M
16.09M
--
--
--
--
--
--
740.36K
16.83M
20.73M
--
10.95M
0.00
--
--
--
--
--
7.34M
--
--
--
5.44M
28.74M
13.41M
--
--
--
9.31M
22.72M
51.46M
249.34K
152.32M
-186.22M
--
--
--
-30.73M
-30.73M
20.73M
FY 2016-09-30
2.35M
--
--
--
--
--
0.00
--
--
--
3.33M
--
5.68M
18.66M
--
--
--
--
--
--
1.07M
19.73M
25.41M
--
5.07M
0.00
--
--
--
--
--
6.12M
--
--
--
3.07M
20.44M
2.55M
--
--
--
7.59M
10.14M
30.58M
228.03K
141.97M
-147.37M
--
--
--
-5.17M
-5.17M
25.41M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out OTLK latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Outlook Therapeutics Inc recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.